المؤلفون: Le QT, Moon J, Redman M, Williamson SK, Lara PN Jr, Goldberg Z, Gaspar LE, Crowley JJ, Moore DF Jr, Gandara DR, Le, Quynh-Thu X, Moon, James, Redman, Mary, Williamson, Stephen K, Lara, Primo N Jr, Goldberg, Zelanna, Gaspar, Laurie E, Crowley, John J, Moore, Dennis F Jr, Gandara, David R

المصدر: Journal of Clinical Oncology; 6/20/2009, Vol. 27 Issue 18, p3014-3019, 6p

المؤلفون: Galanis E, Jaeckle KA, Maurer MJ, Reid JM, Ames MM, Hardwick JS, Reilly JF, Loboda A, Nebozhyn M, Fantin VR, Richon VM, Scheithauer B, Giannini C, Flynn PJ, Moore DF Jr, Zwiebel J, Buckner JC, Galanis, Evanthia, Jaeckle, Kurt A, Maurer, Matthew J

المصدر: Journal of Clinical Oncology; 4/20/2009, Vol. 27 Issue 12, p2052-2058, 7p

المؤلفون: Haddock MG, Swaminathan R, Foster NR, Hauge MD, Martenson JA, Camoriano JK, Stella PJ, Tenglin RC, Schaefer PL, Moore DF Jr, Alberts SR

المصدر: Journal of Clinical Oncology; 6/20/2007, Vol. 25 Issue 18, p2567-2572, 6p

المؤلفون: Hesketh PJ, Crowley JJ, Burris HA III, Williamson SK, Balcerzak SP, Peereboom D, Goodwin JW, Gross HM, Moore DF Jr., Livingston RB, Gandara DR

المصدر: Cancer Journal from Scientific American; Jul/Aug99, Vol. 5 Issue 4, p237-237, 1p

المؤلفون: Choucair K; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Page SJ; Cancer Center of Kansas, Wichita, KS., Mattar BI; Cancer Center of Kansas, Wichita, KS., Dakhil CS; Cancer Center of Kansas, Wichita, KS., Nabbout NH; Cancer Center of Kansas, Wichita, KS., Deutsch JM; Cancer Center of Kansas, Wichita, KS., Truong QV; Cancer Center of Kansas, Wichita, KS., Truong PV; Cancer Center of Kansas, Wichita, KS., Moore DF Jr; Cancer Center of Kansas, Wichita, KS., Cannon MW; Cancer Center of Kansas, Wichita, KS., Kallail KJ; Kansas University School of Medicine, Wichita, KS., Moore JA; Cancer Center of Kansas, Wichita, KS., Dakhil SR; Cancer Center of Kansas, Wichita, KS., Diab R; Kansas University School of Medicine, Wichita, KS., Kamran S; Kansas University School of Medicine, Wichita, KS., Reddy PS; Cancer Center of Kansas, Wichita, KS; Kansas University School of Medicine, Wichita, KS. Electronic address: pavansreddy@gmail.com.

المصدر: Clinical breast cancer [Clin Breast Cancer] 2023 Feb; Vol. 23 (2), pp. 155-161. Date of Electronic Publication: 2022 Nov 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/therapy , Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/drug therapy, Adult ; Humans ; Female ; Retrospective Studies ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/drug therapy ; Receptor, ErbB-2/metabolism ; Genomics ; Risk Assessment ; Chemotherapy, Adjuvant ; Prognosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism

المؤلفون: Hearon BF; Department of Orthopaedics, University of Kansas School of Medicine, Wichita, Kansas, USA., Redelman KN; Kansas Imaging Consultants, Wichita, Kansas, USA., Elhomsy GC; Endocrine Division, Department of Internal Medicine, University of Kansas School of Medicine, Wichita, Kansas, USA., Moore DF Jr; Cancer Center of Kansas, Wichita, Kansas, USA.; Department of Internal Medicine, University of Kansas School of Medicine, Wichita, Kansas, USA.

المصدر: Case reports in oncology [Case Rep Oncol] 2020 Dec 14; Vol. 13 (3), pp. 1483-1489. Date of Electronic Publication: 2020 Dec 14 (Print Publication: 2020).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 101517601 Publication Model: eCollection Cited Medium: Print ISSN: 1662-6575 (Print) Linking ISSN: 16626575 NLM ISO Abbreviation: Case Rep Oncol Subsets: PubMed not MEDLINE

المؤلفون: Algazi AP; University of California, San Francisco, San Francisco, CA, USA. alain.algazi@ucsf.edu., Othus M; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Daud AI; University of California, San Francisco, San Francisco, CA, USA., Lo RS; University of California, Los Angeles, Los Angeles, CA, USA., Mehnert JM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Truong TG; Kaiser Permanente Northern California, Vallejo, CA, USA., Conry R; University of Alabama, Birmingham, Birmingham, AL, USA., Kendra K; Ohio State University, Columbus, OH, USA., Doolittle GC; University of Kansas Hospital-Westwood Cancer Center, Westwood, KS, USA., Clark JI; Loyola University, Chicago, IL, USA., Messino MJ; Messino Cancer Centers-Asheville/ Southeast COR NCORP/Asheville, Asheville, NC, USA., Moore DF Jr; Cancer Center of Kansas/Wichita NCORP, Wichita, KS, USA., Lao C; University of Michigan, Ann Arbor, MI, USA., Faller BA; Missouri Baptist Medical Center Cancer Center/Heartland NCORP, St Louis, MO, USA., Govindarajan R; University of Arkansas, Little Rock, AR, USA., Harker-Murray A; Froedtert and the Medical College of Wisconsin, Milwaukee, WI, USA., Dreisbach L; Eisenhower Medical Center, Rancho Mirage, CA, USA., Moon J; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Grossmann KF; Huntsman Cancer Institute, Salt Lake City, UT, USA., Ribas A; University of California, Los Angeles, Los Angeles, CA, USA.

المصدر: Nature medicine [Nat Med] 2020 Oct; Vol. 26 (10), pp. 1564-1568. Date of Electronic Publication: 2020 Oct 05.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Imidazoles/*administration & dosage , Melanoma/*drug therapy , Oximes/*administration & dosage , Protein Kinase Inhibitors/*administration & dosage , Pyridones/*administration & dosage , Pyrimidinones/*administration & dosage , Skin Neoplasms/*drug therapy, Administration, Oral ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Drug Administration Schedule ; Female ; Humans ; Imidazoles/adverse effects ; MAP Kinase Kinase Kinases/antagonists & inhibitors ; Male ; Melanoma/genetics ; Melanoma/mortality ; Melanoma/pathology ; Middle Aged ; Mutation, Missense ; Oximes/adverse effects ; Protein Kinase Inhibitors/adverse effects ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors ; Proto-Oncogene Proteins B-raf/genetics ; Pyridones/adverse effects ; Pyrimidinones/adverse effects ; Skin Neoplasms/genetics ; Skin Neoplasms/mortality ; Skin Neoplasms/pathology ; Survival Analysis ; Treatment Outcome ; Young Adult

المؤلفون: Jaoude DA; Ascension Via Christi, Wichita, KS., Moore JA; University of Texas Southwestern Medical Center, Dallas, TX., Moore MB; Beth Isreal Deaconess Medical Center, Boston, MA., Twumasi-Ankrah P; Astra Zeneca Pharmaceuticals, Gaithersburg, MD., Ablah E; University of Kansas School of Medicine-Wichita., Moore DF Jr; University of Kansas School of Medicine-Wichita.; Cancer Center of Kansas, Wichita, KS.

المصدر: Kansas journal of medicine [Kans J Med] 2019 Aug 21; Vol. 12 (3), pp. 65-69. Date of Electronic Publication: 2019 Aug 21 (Print Publication: 2019).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The University of Kansas Medical Center Country of Publication: United States NLM ID: 101581958 Publication Model: eCollection Cited Medium: Print ISSN: 1948-2035 (Print) Linking ISSN: 19482035 NLM ISO Abbreviation: Kans J Med Subsets: PubMed not MEDLINE

المؤلفون: Galanis E; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Anderson SK; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Miller CR; Pathobiology and Translational Science Graduate Program, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina., Sarkaria JN; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Jaeckle K; Department of Neurology, Mayo Clinic, Jacksonville, Minnesota., Buckner JC; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Ligon KL; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ballman KV; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Moore DF Jr; Department of Internal Medicine, Cancer Center of Kansas, Wichita, Kansas., Nebozhyn M; Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, Pennsylvania., Loboda A; Data Analysis, Informatics & Analysis Department, Merck Research Laboratories, Boston, Massachusetts., Schiff D; Neuro-Oncology Center, University of Virginia School of Medicine, Charlottesville, Virginia., Ahluwalia MS; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gerstner ER; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts., Lesser GJ; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Prados M; Department of Neurological Surgery, University of California San Francisco, San Francisco, California., Grossman SA; Department of Oncology, Medicine & Neurosurgery, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Cerhan J; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Giannini C; Department of Pathology, Mayo Clinic, Rochester, Minnesota., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

مؤلفون مشاركون: Alliance for Clinical Trials in Oncology and ABTC

المصدر: Neuro-oncology [Neuro Oncol] 2018 Mar 27; Vol. 20 (4), pp. 546-556.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Chemoradiotherapy*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Brain Neoplasms/*therapy , Glioblastoma/*therapy, Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/pathology ; Cohort Studies ; Female ; Follow-Up Studies ; Glioblastoma/pathology ; Humans ; Male ; Maximum Tolerated Dose ; Middle Aged ; Prognosis ; Survival Rate ; Temozolomide/administration & dosage ; Vorinostat/administration & dosage ; Young Adult

المؤلفون: Witzig TE; Division of Hematology, Department of Medicine, Mayo Clinic Rochester, Rochester, Minnesota., Johnston PB; Division of Hematology, Department of Medicine, Mayo Clinic Rochester, Rochester, Minnesota., LaPlant BR; Division of Biomedical Statistics and Bioinformatics, Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, Minnesota., Kurtin PJ; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota., Pederson LD; Division of Biomedical Statistics and Bioinformatics, Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, Minnesota., Moore DF Jr; Cancer Center of Kansas, Wichita, Kansas., Nabbout NH; Cancer Center of Kansas, Wichita, Kansas., Nikcevich DA; Essentia Health Saint Mary's Medical Center, Duluth, Minnesota., Rowland KM; Carle Cancer Center CCOP, Urbana, Illinois., Grothey A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.

المصدر: American journal of hematology [Am J Hematol] 2017 Oct; Vol. 92 (10), pp. 1004-1010. Date of Electronic Publication: 2017 Aug 17.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD20/*immunology , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Drug-Related Side Effects and Adverse Reactions/*etiology , Lymphoma, B-Cell/*drug therapy, Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cytarabine/administration & dosage ; Cytarabine/adverse effects ; Cytarabine/therapeutic use ; Dexamethasone/administration & dosage ; Dexamethasone/adverse effects ; Dexamethasone/therapeutic use ; Disease-Free Survival ; Drug Administration Schedule ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Female ; Filgrastim ; Follow-Up Studies ; Granulocyte Colony-Stimulating Factor/administration & dosage ; Granulocyte Colony-Stimulating Factor/adverse effects ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans ; Kaplan-Meier Estimate ; Lymphoma, B-Cell/immunology ; Lymphoma, B-Cell/mortality ; Lymphoma, B-Cell/pathology ; Male ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/adverse effects ; Organoplatinum Compounds/therapeutic use ; Oxaliplatin ; Polyethylene Glycols ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/adverse effects ; Recombinant Proteins/therapeutic use ; Rituximab/administration & dosage ; Rituximab/adverse effects ; Rituximab/therapeutic use